Sort   by:  
 Page size 
UnknownComparative Immune Response after Vaccination with SOBERANA® 02 and SOBERANA® plus Heterologous Scheme and Natural Infection in Young Children.
Not available
S-EPMC10675375 | biostudies-literature
UnknownSafety and Cross-Neutralizing Immunity Against SARS-CoV-2 Omicron Sub-Variant After a Booster Dose with SOBERANA<sup>®</sup> Plus in Children and Adolescents.
Not available
S-EPMC12737616 | biostudies-literature
UnknownDouble-task exercise programmes to strengthen cognitive and vascular health in older adults at risk of cognitive decline: protocol for a randomised clinical trial.
Not available
S-EPMC7780518 | biostudies-literature
UnknownOpen-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in children.
Not available
S-EPMC9673084 | biostudies-literature
UnknownSafety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials.
Not available
S-EPMC9167831 | biostudies-literature
UnknownCross-cultural invariance of the Spanish version of the COVID-19 Assessment Scorecard to measure the perception of government actions against COVID-19 in Latin America.
Not available
S-EPMC10632328 | biostudies-literature
UnknownEvidence of spatial clustering of childhood acute lymphoblastic leukemia cases in Greater Mexico City: report from the Mexican Inter-Institutional Group for the identification of the causes of childhood leukemia.
Not available
S-EPMC10899509 | biostudies-literature
UnknownA greater birthweight increases the risk of acute leukemias in Mexican children-experience from the Mexican Interinstitutional Group for the Identification of the Causes of Childhood Leukemia (MIGICCL).
Not available
S-EPMC5911591 | biostudies-literature
UnknownRepurposed Antiviral Drugs for Covid-19 - Interim WHO Solidarity Trial Results.
Not available
S-EPMC7727327 | biostudies-literature
UnknownCOVID-19-associated venous thromboembolism: risk of recurrence and major bleeding.
Not available
S-EPMC10569976 | biostudies-literature
Sort   by:  
 Page size